Deputy Head of the Gamaleya Logunov Center: the nasal vaccine against COVID-19 has a minimum of side effects 
Deputy Director of the National Research Center of Epidemiology and F. Gamalei Denis Logunov spoke about the benefits of a nasal vaccine against coronavirus. According to him, the use of the drug will help form additional immune protection against COVID-19 in the upper respiratory tract, reports TASS.
The nasal vaccine has a minimum of side effects, said the deputy head of the Gamaleya Center. He added that its application is convenient and painless. In addition, he revealed the main function of such a drug.
Related materials 00:01 – November 12 
“There will always be disagreements” Some Russians deny coronavirus and do not want to be vaccinated. How to convince them? 13:43 – November 1 
Scientists have discovered a new drug for COVID-19. COVID-19
“And plus we will achieve the most important thing: after the primary parenteral vaccination, we will have systemic immunity, after additional intranasal immunization, we will create an additional barrier in the form of immunity in the upper respiratory tract,” Logunov said at a meeting with Russian President Vladimir Putin./p>
The specialist added that they plan to use the nasal vaccine soon after the end of clinical trials.
At a meeting with Logunov, Putin said that he was ready to take part in trials of a nasal vaccine against COVID-19. The Russian president promised to sign the necessary consent for this, perhaps even today.
The Russian Ministry of Health in October allowed the Gamaleya Center to conduct the second phase of clinical trials of a coronavirus vaccine in the form of a nasal spray. The director of the institution, Alexander Gintsburg, said that this vaccine would not cancel the need for routine vaccinations. The nasal drug complements it, creating another barrier to the coronavirus.